Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday, BidAskClub reports.
Several other equities analysts have also recently issued reports on the stock. GMP Securities started coverage on shares of Neptune Wellness Solutions in a research note on Tuesday, April 9th. They issued a “buy” rating for the company. Zacks Investment Research upgraded shares of Neptune Wellness Solutions from a “hold” rating to a “buy” rating and set a $3.75 target price for the company in a research note on Wednesday, March 13th. Finally, Echelon Wealth Partners reiterated a “buy” rating on shares of Neptune Wellness Solutions in a research note on Wednesday, January 9th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $3.75.
NEPT opened at $4.13 on Tuesday. Neptune Wellness Solutions has a 1 year low of $2.31 and a 1 year high of $5.14. The firm has a market capitalization of $322.24 million, a P/E ratio of 24.29 and a beta of 1.84.
Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) last posted its earnings results on Wednesday, February 13th. The biotechnology company reported ($0.04) earnings per share (EPS) for the quarter. Neptune Wellness Solutions had a negative net margin of 60.48% and a negative return on equity of 18.85%. The firm had revenue of $4.95 million during the quarter. Research analysts anticipate that Neptune Wellness Solutions will post -0.06 earnings per share for the current year.
Several institutional investors and hedge funds have recently bought and sold shares of NEPT. Parallel Advisors LLC lifted its stake in shares of Neptune Wellness Solutions by 25.0% in the 4th quarter. Parallel Advisors LLC now owns 20,000 shares of the biotechnology company’s stock valued at $50,000 after purchasing an additional 4,000 shares during the period. Fisher Asset Management LLC acquired a new position in shares of Neptune Wellness Solutions in the 4th quarter valued at $51,000. Wells Fargo & Company MN lifted its stake in shares of Neptune Wellness Solutions by 236,363.6% in the 3rd quarter. Wells Fargo & Company MN now owns 26,011 shares of the biotechnology company’s stock valued at $101,000 after purchasing an additional 26,000 shares during the period. Renaissance Technologies LLC lifted its stake in shares of Neptune Wellness Solutions by 696.0% in the 3rd quarter. Renaissance Technologies LLC now owns 93,654 shares of the biotechnology company’s stock valued at $363,000 after purchasing an additional 81,889 shares during the period. Finally, Two Sigma Advisers LP acquired a new position in shares of Neptune Wellness Solutions in the 4th quarter valued at $367,000. Hedge funds and other institutional investors own 14.67% of the company’s stock.
Neptune Wellness Solutions Company Profile
Neptune Wellness Solutions Inc, a health and wellness products company, engages in the extraction, purification, and formulation of value-added differentiated science based products. It develops turnkey nutrition product solutions in various delivery forms. The company offers specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.
Recommended Story: Price-Sales Ratio
Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.